Biofourmis Raises Additional Funding from Intel Capital in Series D Extension and Names Top Healthcare Leaders to its Board
Healthcare IT Today
AUGUST 25, 2022
Jain, physician executive with government, pharmaceutical, payer and provider experience, joins Board. Biofourmis continues to buck health tech funding trends with this Series D extension, which comes during a downturn in digital health investment. billion—down from $14.7
Let's personalize your content